TR200201211T2 - Pulmoner hastalıkların tedavisi için metod ve terkipler. - Google Patents

Pulmoner hastalıkların tedavisi için metod ve terkipler.

Info

Publication number
TR200201211T2
TR200201211T2 TR2002/01211T TR200201211T TR200201211T2 TR 200201211 T2 TR200201211 T2 TR 200201211T2 TR 2002/01211 T TR2002/01211 T TR 2002/01211T TR 200201211 T TR200201211 T TR 200201211T TR 200201211 T2 TR200201211 T2 TR 200201211T2
Authority
TR
Turkey
Prior art keywords
treatment
compositions
methods
pulmonary diseases
diseases
Prior art date
Application number
TR2002/01211T
Other languages
English (en)
Turkish (tr)
Inventor
N. Goodfellow Peter
Nieman Richard
J. Torphy Theodore
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200201211T2 publication Critical patent/TR200201211T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2002/01211T 1999-11-02 2000-11-01 Pulmoner hastalıkların tedavisi için metod ve terkipler. TR200201211T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
TR200201211T2 true TR200201211T2 (tr) 2002-08-21

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01211T TR200201211T2 (tr) 1999-11-02 2000-11-01 Pulmoner hastalıkların tedavisi için metod ve terkipler.

Country Status (29)

Country Link
EP (1) EP1225866A4 (xx)
JP (1) JP2003513028A (xx)
KR (1) KR20020057988A (xx)
CN (1) CN1387404A (xx)
AP (1) AP2002002496A0 (xx)
AR (1) AR029189A1 (xx)
AU (1) AU1357501A (xx)
BG (1) BG106748A (xx)
BR (1) BR0015270A (xx)
CA (1) CA2388333A1 (xx)
CO (1) CO5261512A1 (xx)
CZ (1) CZ20021512A3 (xx)
DZ (1) DZ3225A1 (xx)
EA (1) EA200200518A1 (xx)
EC (1) ECSP003747A (xx)
HK (1) HK1049107A1 (xx)
HU (1) HUP0203152A3 (xx)
IL (1) IL149367A0 (xx)
MA (1) MA26841A1 (xx)
MX (1) MXPA02004350A (xx)
NO (1) NO20022057L (xx)
OA (1) OA12076A (xx)
PE (1) PE20011005A1 (xx)
PL (1) PL355261A1 (xx)
SK (1) SK7592002A3 (xx)
TR (1) TR200201211T2 (xx)
TW (1) TWI242431B (xx)
WO (1) WO2001032127A2 (xx)
ZA (1) ZA200203435B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1429807E (pt) 2001-09-19 2007-05-31 Altana Pharma Ag Combinação de um nsaid e de um inibidor de pde-4
EP1463509A1 (en) * 2001-10-31 2004-10-06 MERCK PATENT GmbH Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CA2520577A1 (en) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
RU2008119322A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Композиции ингибиторов фосфодиэстеразы iv типа
CA2784041C (en) 2010-01-05 2017-11-07 Microdose Therapeutx, Inc. Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08511805A (ja) * 1993-06-18 1996-12-10 スミスクライン・ビーチャム・コーポレイション 化合物
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
PE20011005A1 (es) 2001-09-28
AR029189A1 (es) 2003-06-18
CA2388333A1 (en) 2001-05-10
IL149367A0 (en) 2002-11-10
MA26841A1 (fr) 2004-12-20
DZ3225A1 (fr) 2001-05-10
CZ20021512A3 (cs) 2003-04-16
EP1225866A4 (en) 2004-04-21
CO5261512A1 (es) 2003-03-31
CN1387404A (zh) 2002-12-25
ECSP003747A (es) 2002-05-23
SK7592002A3 (en) 2002-11-06
HUP0203152A2 (hu) 2003-01-28
HUP0203152A3 (en) 2004-06-28
PL355261A1 (en) 2004-04-05
NO20022057D0 (no) 2002-04-30
TWI242431B (en) 2005-11-01
JP2003513028A (ja) 2003-04-08
BG106748A (en) 2003-02-28
EP1225866A2 (en) 2002-07-31
ZA200203435B (en) 2003-06-25
MXPA02004350A (es) 2002-11-07
NO20022057L (no) 2002-06-27
EA200200518A1 (ru) 2002-10-31
AU1357501A (en) 2001-05-14
KR20020057988A (ko) 2002-07-12
AP2002002496A0 (en) 2002-06-30
WO2001032127A3 (en) 2001-12-06
WO2001032127A2 (en) 2001-05-10
HK1049107A1 (zh) 2003-05-02
OA12076A (en) 2006-05-04
BR0015270A (pt) 2002-06-18

Similar Documents

Publication Publication Date Title
TR200100500T2 (tr) Pulmoner hastalıkların tedavisi için terapiler
UY28958A1 (es) Nuevos derivados de piridazin-3(2h)-ona
ATE486840T1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
ECSP12006206A (es) Inhibidores de quinasa p38 basados en heterociclos de 5 miembros.
TR200102110T2 (tr) Astım için formoterol ve flütikazon propiyonat kombinasyonları.
BRPI0407922A (pt) derivados de isoquinolina e métodos de uso destes
CY1108274T1 (el) Μακροβιο ομοιαζον με γλυκογονο πεπτιδιο 2 (glp-2) για την θεραπεια γαστρεντερικων ασθενειων και διαταραχων
WO2001083554A3 (en) Anti-inflammatory compounds and uses thereof
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
WO2002034726A3 (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
WO2003011274A3 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
TR200201211T2 (tr) Pulmoner hastalıkların tedavisi için metod ve terkipler.
WO2000045800A3 (en) Immunosurpressive effects of pteridine derivatives
MXPA03008423A (es) Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias.
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
SE9900833D0 (sv) Novel combination
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
PT1268472E (pt) Inibidores 3-aminopirazolicos de cinases dependentes da ciclina
TR200102448T2 (tr) COPD tedavisi için kontrollu salma formülasyonu.
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
SE9900834D0 (sv) Novel combination
HUP0301257A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és topoizomeráz I és II inhibitorokat tartalmazó kombinált tumorellenes kompozíciók